tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Brian Cheng, 33 are a BUY (75%), 10 are a HOLD (22.73%), 1 are a SELL (2.27%).
Analyst Brian Cheng works with a stock forecast success ratio of 30.95% fulfilled within 41 days on average. Previously, Brian Cheng worked at JPMORGAN.
Brian Cheng’s has documented 87 price targets and ratings displayed on 16 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on PTGX, Protagonist Therapeutics at 28-Feb-2024.
Analyst best performing recommendations are on APLS (APELLIS PHARMACEUTICALS).
The best stock recommendation documented was for APLS (APELLIS PHARMACEUTICALS) at 10/12/2023. The price target of $46 was fulfilled within 1 day with a profit of $2.1 (4.78%) receiving and performance score of 47.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
87
$59.94 (221.51%)
1 months 13 days ago
1/2 (50%)
$49.11 (129.61%)
75
Buy
48
$20.94 (77.38%)
40
2 months 16 days ago
4/8 (50%)
$10.09 (26.62%)
195
Buy
51
$23.94 (88.47%)
51
4 months 27 days ago
14/24 (58.33%)
$25.48 (99.84%)
165
Buy
54
$26.94 (99.56%)
54
8 months 2 days ago
2/5 (40%)
$21.39 (65.59%)
548
Buy
36
9 months 10 days ago
2/2 (100%)
$15.83 (78.48%)
271
Which stock is Brian Cheng is most bullish on?
Which stock is Brian Cheng is most reserved on?
What Year was the first public recommendation made by Brian Cheng?
